AIPL1 antibody
Principal name
AIPL1 antibody
Alternative names for AIPL1 antibody
Aryl-hydrocarbon-interacting protein-like 1
Ncbi ID
NP_055151, 9606, NP_001028226.1, NP_444475.2, BC028285, NM_053245, NM_021590, NM_001033054
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Luminex (LMNX)
Background of AIPL1 antibody
Aipl1 was initially identified as a protein implicated in Leber congenital amaurosis (LCA), an autosomal recessive disorder thought to be caused by the abnormal development of photoreceptors. Aipl1 is a tetratricopeptide repeat protein that is highly homologous to ARA9, a protein involved in the HSP90-mediated nuclear translocation and transactivation of the aryl hydrocarbon receptor. Aipl1 has also been found to function as part of a chaperone heterocomplex, interacting with Hsp90 and Hsp70. Aipl1 also associates with the cell cycle regulator NUB1. It is thought that Aipl1 cooperates with Hsp70 but not Hsp90 to suppress the formation of NUB1 inclusions, and these interactions are necessary in the normal photoreceptor maturation, as mutations that lead to LCA also compromise the interactions with the Hsp chaperones. At least three isoforms of Aipl1 are known to exist.
Immunoperoxidase of monoclonal antibody to AIPL1 on formalin-fixed paraffin-embedded human placenta. [antibody concentration 3 ug/ml]
Western Blot analysis of AIPL1 expression in transfected 293T cell line by AIPL1 monoclonal antibody (M04), clone 1E1.Lane 1: AIPL1 transfected lysate(43.9 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of AIPL1 expression in transfected 293T cell line (H00023746-T01) by AIPL1 MaxPab polyclonal antibody.Lane 1: AIPL1 transfected lysate(42.24 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of AIPL1 expression in transfected 293T cell line (H00023746-T01) by AIPL1 MaxPab polyclonal antibody.Lane 1: AIPL1 transfected lysate(42.24 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of AIPL1 expression in transfected 293T cell line (H00023746-T01) by AIPL1 MaxPab polyclonal antibody.Lane 1: AIPL1 transfected lysate(43.90 KDa).Lane 2: Non-transfected lysate.
Human Adrenal: Formalin-Fixed, Paraffin-Embedded (FFPE)
Western blot analysis of Aipl1 in human brain tissue lysate with Aipl1 antibody (AP22992PU-N) at (A) 1 and (B) 2 µg/ml
Ganglion cells: Formalin-Fixed, Paraffin-Embedded (FFPE)
Western blot analysis of Aipl1 in rat brain tissue lysate with Aipl1 antibody (AP22998PU-N) at (A) 1 and (B) 2 µg/ml
Anti-AIPL1 mouse monoclonal antibody (TA503572) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1(RC204079).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (RC204079, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.
HEK293T cells transfected with either RC204079 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-AIPL1 antibody(TA503572), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-AIPL1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA503693)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-AIPL1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA503693)
Immunohistochemical staining of paraffin-embedded Human lymph node tissue within the normal limits using anti-AIPL1 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA503693)
Anti-AIPL1 mouse monoclonal antibody (TA503693) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1(RC204079).
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-AIPL1 monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (RC204079, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.
HEK293T cells transfected with either RC204079 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-AIPL1 antibody(TA503693), and then analyzed by flow cytometry.
Anti-AIPL1 mouse monoclonal antibody (TA503694) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1(RC204079).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (RC204079, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.
HEK293T cells transfected with either RC204079 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-AIPL1 antibody(TA503694), and then analyzed by flow cytometry.
Anti-AIPL1 mouse monoclonal antibody (TA503695) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1(RC204079).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (RC204079, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-AIPL1 monoclonal antibody.
HEK293T cells transfected with either RC204079 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-AIPL1 antibody(TA503695), and then analyzed by flow cytometry.
AIPL1 Luminex with 2D11 Capture (TA600079) and 3B4 Detection (TA700080) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 2D11 Capture (TA600079) and 2B11 Detection (TA700131) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 ELISA with 3B4 Capture (TA600080) and 2B11 Detection (TA700131) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 ELISA with 3B4 Capture (TA600080) and 2D11 Detection (TA700079) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 3B4 Capture (TA600080) and 2B11 Detection (TA700131) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 3B4 Capture (TA600080) and 2D11 Detection (TA700079) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 ELISA with 3B4 Capture (TA600080) and 2D11 Detection (TA700079) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 3B4 Capture (TA600080) and 2D11 Detection (TA700079) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 2D11 Capture (TA600079) and 3B4 Detection (TA700080) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 ELISA with 3B4 Capture (TA600080) and 2B11 Detection (TA700131) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 3B4 Capture (TA600080) and 2B11 Detection (TA700131) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
AIPL1 Luminex with 2D11 Capture (TA600079) and 2B11 Detection (TA700131) Antibodies. Substrate used: Recombinant Human AIPL1 (TP304079)
Western blot analysis of Aipl1 in human brain tissue lysate with Aipl1 antibody at (A) 1 and (B) 2 ug/ml.
Immunohistochemistry of Aipl1 in human brain tissue with Aipl1 antibody at 2.5 ug/ml.
Immunofluorescence of aipl1 in human brain tissue with aipl1 antibody at 20 ug/mL.
Western blot analysis of Aipl1 in rat brain tissue lysate with Aipl1 antibody at (A) 1 and (B) 2 ug/ml.
Immunohistochemistry of Aipl1 in human brain tissue with Aipl1 antibody at 2.5 ug/ml.
Immunofluorescence of aipl1 in human brain tissue with aipl1 antibody at 20 ug/mL.
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA600080 | AIPL1 antibody |
||||||
| ELISA and Luminex validated AIPL1 mouse monoclonal antibody (clone 3B4, clone OTI3B4 (formerly 3B4) | |||||||
 |
Mouse | IgG1 | OTI3B4 | Purified | Hu | E, LMNX |
0.1 mg /
$350.00
|
| OriGene Technologies, Inc. | |||||||
 +4 additional images |
Highly validated antibody! |
||||||
| TA600079 | AIPL1 antibody |
||||||
| Luminex validated AIPL1 mouse monoclonal antibody (clone 2D1, clone OTI2D11 (formerly 2D11) | |||||||
 |
Mouse | IgG1 | OTI2D11 | Purified | Hu | LMNX |
0.1 mg /
$360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA700079 | AIPL1 antibody |
||||||
| ELISA and Luminex validated biotinylated AIPL1 mouse monoclonal antibody (clone 2D11), clone OTI2D11 (formerly 2D11) | |||||||
 |
Mouse | IgG1 | OTI2D11 | Purified | Hu | E, LMNX |
50 µg /
$360.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA700080 | AIPL1 antibody |
||||||
| Luminex validated biotinylated AIPL1 mouse monoclonal antibody (clone 3B4), clone OTI3B4 (formerly 3B4) | |||||||
 |
Mouse | IgG1 | OTI3B4 | Purified | Hu | LMNX |
50 µg /
$360.00
|
| OriGene Technologies, Inc. | |||||||
| TA700131 | AIPL1 antibody |
||||||
| ELISA and Luminex validated biotinylated AIPL1 mouse monoclonal antibody (clone 2B11), clone OTI2B11 (formerly 2B11) | |||||||
 |
Mouse | IgG1 | OTI2B11 | Purified | Hu | E, LMNX |
50 µg /
$360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||